vs
亚什兰（ASH）与ZoomInfo Technologies Inc.（GTM）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是ZoomInfo Technologies Inc.的1.2倍（$386.0M vs $319.1M），ZoomInfo Technologies Inc.净利率更高（10.9% vs -3.1%，领先14.0%），ZoomInfo Technologies Inc.同比增速更快（3.2% vs -4.7%），ZoomInfo Technologies Inc.自由现金流更多（$127.1M vs $111.0M），过去两年ZoomInfo Technologies Inc.的营收复合增速更高（1.4% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
ZoomInfo Technologies Inc.是美国合规注册的数据服务商，通过数据采集、网页抓取等多元渠道汇总公开及非公开个人数据，同时收集企业、部门等商业主体信息，面向企业客户提供相关数据产品，助力客户开展精准营销等业务活动。
ASH vs GTM — 直观对比
营收规模更大
ASH
是对方的1.2倍
$319.1M
营收增速更快
GTM
高出7.9%
-4.7%
净利率更高
GTM
高出14.0%
-3.1%
自由现金流更多
GTM
多$16.1M
$111.0M
两年增速更快
GTM
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $319.1M |
| 净利润 | $-12.0M | $34.7M |
| 毛利率 | 27.2% | 84.0% |
| 营业利润率 | -1.6% | 17.0% |
| 净利率 | -3.1% | 10.9% |
| 营收同比 | -4.7% | 3.2% |
| 净利润同比 | 92.7% | 137.7% |
| 每股收益（稀释后） | $-0.26 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHGTM
| Q4 25 | $386.0M | $319.1M | ||
| Q3 25 | $477.0M | $318.0M | ||
| Q2 25 | $463.0M | $306.7M | ||
| Q1 25 | $479.0M | $305.7M | ||
| Q4 24 | $405.0M | $309.1M | ||
| Q3 24 | $521.0M | $303.6M | ||
| Q2 24 | $544.0M | $291.5M | ||
| Q1 24 | $575.0M | $310.1M |
净利润ASHGTM
| Q4 25 | $-12.0M | $34.7M | ||
| Q3 25 | $31.0M | $38.7M | ||
| Q2 25 | $-742.0M | $24.0M | ||
| Q1 25 | $31.0M | $26.8M | ||
| Q4 24 | $-165.0M | $14.6M | ||
| Q3 24 | $17.0M | $23.8M | ||
| Q2 24 | $6.0M | $-24.4M | ||
| Q1 24 | $120.0M | $15.1M |
毛利率ASHGTM
| Q4 25 | 27.2% | 84.0% | ||
| Q3 25 | 33.3% | 83.7% | ||
| Q2 25 | 28.5% | 83.9% | ||
| Q1 25 | 30.7% | 84.5% | ||
| Q4 24 | 27.4% | 82.8% | ||
| Q3 24 | 33.2% | 84.4% | ||
| Q2 24 | 34.2% | 84.3% | ||
| Q1 24 | 28.0% | 86.0% |
营业利润率ASHGTM
| Q4 25 | -1.6% | 17.0% | ||
| Q3 25 | 12.8% | 21.2% | ||
| Q2 25 | -152.9% | 17.5% | ||
| Q1 25 | 10.6% | 16.5% | ||
| Q4 24 | -44.2% | 10.0% | ||
| Q3 24 | 6.1% | 14.3% | ||
| Q2 24 | -11.2% | -6.9% | ||
| Q1 24 | 3.7% | 13.9% |
净利率ASHGTM
| Q4 25 | -3.1% | 10.9% | ||
| Q3 25 | 6.5% | 12.2% | ||
| Q2 25 | -160.3% | 7.8% | ||
| Q1 25 | 6.5% | 8.8% | ||
| Q4 24 | -40.7% | 4.7% | ||
| Q3 24 | 3.3% | 7.8% | ||
| Q2 24 | 1.1% | -8.4% | ||
| Q1 24 | 20.9% | 4.9% |
每股收益（稀释后）ASHGTM
| Q4 25 | $-0.26 | $0.11 | ||
| Q3 25 | $0.83 | $0.12 | ||
| Q2 25 | $-16.21 | $0.07 | ||
| Q1 25 | $0.65 | $0.08 | ||
| Q4 24 | $-3.50 | $0.04 | ||
| Q3 24 | $0.34 | $0.07 | ||
| Q2 24 | $0.12 | $-0.07 | ||
| Q1 24 | $2.39 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $179.9M |
| 总债务越低越好 | $1.4B | $1.3B |
| 股东权益账面价值 | $1.9B | $1.5B |
| 总资产 | $4.5B | $6.4B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.88× |
8季度趋势，按日历期对齐
现金及短期投资ASHGTM
| Q4 25 | $304.0M | $179.9M | ||
| Q3 25 | $215.0M | $135.0M | ||
| Q2 25 | $207.0M | $176.9M | ||
| Q1 25 | $168.0M | $140.5M | ||
| Q4 24 | $219.0M | $139.9M | ||
| Q3 24 | $300.0M | $147.7M | ||
| Q2 24 | $399.0M | $399.3M | ||
| Q1 24 | $439.0M | $440.2M |
总债务ASHGTM
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $1.3B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.3B | $1.2B | ||
| Q3 24 | $1.3B | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.3B | $1.2B |
股东权益ASHGTM
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $1.9B | $1.5B | ||
| Q2 25 | $1.9B | $1.6B | ||
| Q1 25 | $2.6B | $1.6B | ||
| Q4 24 | $2.6B | $1.7B | ||
| Q3 24 | $2.9B | $1.7B | ||
| Q2 24 | $3.0B | $1.9B | ||
| Q1 24 | $3.1B | $2.0B |
总资产ASHGTM
| Q4 25 | $4.5B | $6.4B | ||
| Q3 25 | $4.6B | $6.4B | ||
| Q2 25 | $4.6B | $6.5B | ||
| Q1 25 | $5.2B | $6.4B | ||
| Q4 24 | $5.2B | $6.5B | ||
| Q3 24 | $5.6B | $6.4B | ||
| Q2 24 | $5.7B | $6.7B | ||
| Q1 24 | $5.9B | $6.8B |
负债/权益比ASHGTM
| Q4 25 | 0.74× | 0.88× | ||
| Q3 25 | 0.73× | 0.87× | ||
| Q2 25 | 0.73× | 0.85× | ||
| Q1 25 | 0.52× | 0.75× | ||
| Q4 24 | 0.51× | 0.72× | ||
| Q3 24 | 0.47× | 0.74× | ||
| Q2 24 | 0.45× | 0.66× | ||
| Q1 24 | 0.42× | 0.61× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $143.5M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $127.1M |
| 自由现金流率自由现金流/营收 | 28.8% | 39.8% |
| 资本支出强度资本支出/营收 | 3.6% | 5.1% |
| 现金转化率经营现金流/净利润 | — | 4.14× |
| 过去12个月自由现金流最近4个季度 | $200.0M | $389.3M |
8季度趋势，按日历期对齐
经营现金流ASHGTM
| Q4 25 | $125.0M | $143.5M | ||
| Q3 25 | $40.0M | $93.8M | ||
| Q2 25 | $115.0M | $108.9M | ||
| Q1 25 | $9.0M | $119.2M | ||
| Q4 24 | $-30.0M | $109.0M | ||
| Q3 24 | $80.0M | $18.2M | ||
| Q2 24 | $127.0M | $126.3M | ||
| Q1 24 | $54.0M | $115.9M |
自由现金流ASHGTM
| Q4 25 | $111.0M | $127.1M | ||
| Q3 25 | $6.0M | $70.9M | ||
| Q2 25 | $95.0M | $86.9M | ||
| Q1 25 | $-12.0M | $104.4M | ||
| Q4 24 | $-53.0M | $85.6M | ||
| Q3 24 | $42.0M | $600.0K | ||
| Q2 24 | $98.0M | $115.2M | ||
| Q1 24 | $20.0M | $103.1M |
自由现金流率ASHGTM
| Q4 25 | 28.8% | 39.8% | ||
| Q3 25 | 1.3% | 22.3% | ||
| Q2 25 | 20.5% | 28.3% | ||
| Q1 25 | -2.5% | 34.2% | ||
| Q4 24 | -13.1% | 27.7% | ||
| Q3 24 | 8.1% | 0.2% | ||
| Q2 24 | 18.0% | 39.5% | ||
| Q1 24 | 3.5% | 33.2% |
资本支出强度ASHGTM
| Q4 25 | 3.6% | 5.1% | ||
| Q3 25 | 7.1% | 7.2% | ||
| Q2 25 | 4.3% | 7.2% | ||
| Q1 25 | 4.4% | 4.8% | ||
| Q4 24 | 5.7% | 7.6% | ||
| Q3 24 | 7.3% | 5.8% | ||
| Q2 24 | 5.3% | 3.8% | ||
| Q1 24 | 5.9% | 4.1% |
现金转化率ASHGTM
| Q4 25 | — | 4.14× | ||
| Q3 25 | 1.29× | 2.42× | ||
| Q2 25 | — | 4.54× | ||
| Q1 25 | 0.29× | 4.45× | ||
| Q4 24 | — | 7.47× | ||
| Q3 24 | 4.71× | 0.76× | ||
| Q2 24 | 21.17× | — | ||
| Q1 24 | 0.45× | 7.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
GTM
暂无分部数据
